Mohr Davidow Ventures related stories
All articles and analysis
- OPX Biotechnologies Closes on $36.5M Series C
OPX Biotechnologies Inc. has closed on $36.5 million in a first close of its Series C round, the company said Thursday. US Renewables Group led the round, which included investment from new investor DBL Investors and from existing investors Mohr Davidow Ventures, Braemar Energy Ventures, Altira Group and X/Seed Capital. Pacific Crest Securities provided financial advice to OPXBIO. As a result of the round, US Renewables Group managing director Jonathan Koch has joined the OPXBIO board. The company will use the money for development and commercialization of an industrial-scale process for producing its first renewable chemical, BioAcrylic.
- On the Rise: Internet M&A
Acquisitions are flying high as VCs cash in on their Web 2.0 bets. Expect a second half surge of activity
On the Rise: Internet M&AAcquisitions are flying high as VCs cash in on their Web 2.0 bets. Expect a second half surge of activity
- VC People Moves, July 2011
New hires and promotions at Venrock, Kleiner Perkins, VantagePoint, Canaan and other VC firms
- Rally Software Gets Meritech Injection
Rally Software, the Colorado-based software technology firm, has secured a $20 million round of fundraising from Meritech Capital Partners. Prior investors and debt providers include Mohr Davidow Ventures, Boulder Ventures, Mobius Venture Capital and Vista Ventures as well as Square 1 Bank.
- Aryaka Closes $15M Series B
Aryaka, a provider of first cloud-based WAN optimization and application acceleration technology, has closed on $15 million in Series B financing. Nexus Venture Partners led the round, which included participation from Trinity Ventures and Mohr Davidow Ventures. The company previously raised $14 million in a first round. The new cash will help Aryaka expand marketing and sales for its software-as-a-service.
- Job Moves: Kleiner Lures Huang from Vivo, CalPERS Gets Real, Founders Fund CFO Moves On, More
In this week's installment of Job Moves, we look at Kleiner Perkins' latest hire and the firm he left; a key private equity appointment for the nation's largest pension fund; a new fund for two former Insight GPs; a Brazilian expansion; and another very large pension fund that looks to be hiring. KP HIRES HUANG FROM VIVO Just a few days after Vivo Ventures announced the promotion of a partner to head its China operations, Kleiner Perkins Caufield & Byers announced /107715/james-huang-joins-kpcb-in-shanghai/ that it has hired former Vivo partner James Huang to advise on life science investments as a partner in its Shanghai office. Huang was a managing partner at Vivo and, previously,